Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary...

Autor: Selker HP, Beshansky JR, Griffith JL, D'Agostino RB, Massaro JM, Udelson JE, Rashba EJ, Ruthazer R, Sheehan PR, Desvigne-Nickens P, Rosenberg YD, Atkins JM, Sayah AJ, Aufderheide TP, Rackley CE, Opie LH, Lambrew CT, Cobb LA, Macleod BA, Ingwall JS

Publikováno v: American Heart Journal; Mar2012, Vol. 163 Issue 3, p315-322, 8p

The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: A secondary analysis of the D2d study.

Autor: Desouza C; Omaha VA Medical Center, University of Nebraska Medical Center, Omaha, NE, United States of America. Electronic address: cdesouza@unmc.edu., Chatterjee R; Department of Medicine, Duke University, Durham, NC, United States of America., Vickery EM; Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA, United States of America., Nelson J; Tufts CTSI, BERD Center, Tufts Medical Center, Boston, MA, United States of America., Johnson KC; Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, United States of America., Kashyap SR; Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH, United States of America., Lewis MR; Department of Pathology, Banner MD Anderson Cancer Center, Gilbert, AZ, United State of America., Margolis K; Health Partners Institute, Minneapolis, MN, United States of America., Pratley R; AdventHealth Translational Research Institute, Orlando, FL, United States of America., Rasouli N; University of Colorado, School of Medicine and VA Eastern Colorado Health Care System, Aurora, CO, United States of America., Sheehan PR; Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA, United States of America., Pittas AG; Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA, United States of America.

Publikováno v: Journal of diabetes and its complications [J Diabetes Complications] 2022 Aug; Vol. 36 (8), pp. 108230. Date of Electronic Publication: 2022 Jun 12.

Vitamin D Supplementation for Prevention of Cancer: The D2d Cancer Outcomes (D2dCA) Ancillary Study.

Autor: Chatterjee R; Department of Medicine, Duke University, Durham, NC 27713, USA., Fuss P; Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA 02111, USA., Vickery EM; Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA 02111, USA., LeBlanc ES; Center for Health Research, Kaiser Permanente NW, Portland, OR 97227, USA., Sheehan PR; Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA 02111, USA.; Spaulding Rehabilitation Network, Boston, MA 02129, USA.; Tufts Medical Center, Boston, MA 02129, USA., Lewis MR; Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT 05401, USA., Dolor RJ; Department of Medicine, Duke University, Durham, NC 27713, USA., Johnson KC; Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN 38105, USA., Kashyap SR; Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH 44195, USA., Nelson J; Tufts CTSI, BERD Center, Tufts Medical Center, Boston, MA 02111, USA., Pittas AG; Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA 02111, USA.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2021 Aug 18; Vol. 106 (9), pp. 2767-2778.

Establishing an electronic health record-supported approach for outreach to and recruitment of persons at high risk of type 2 diabetes in clinical trials: The vitamin D and type 2 diabetes (D2d) study experience.

Autor: Aroda VR; 1 MedStar Health Research Institute, Hyattsville, MD, USA.; 2 Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Sheehan PR; 3 Tufts Medical Center, Boston, MA, USA., Vickery EM; 3 Tufts Medical Center, Boston, MA, USA., Staten MA; 4 KGS for The National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA., LeBlanc ES; 5 Kaiser Permanente Center for Health Research NW, Portland, OR, USA., Phillips LS; 6 Atlanta VA Medical Center, Decatur, GA, USA.; 7 Emory University School of Medicine, Atlanta, GA, USA., Brodsky IG; 8 Maine Medical Center, Scarborough, ME, USA., Chadha C; 9 HealthPartners, Minneapolis, MN, USA., Chatterjee R; 10 Duke University School of Medicine, Durham, NC, USA., Ouellette MG; 11 University of Kansas Medical Center, Kansas City, KS, USA.; 12 Georgia Department of Public Health, Atlanta, GA, USA., Desouza C; 13 University of Nebraska Medical Center, Omaha, NE, USA., Pittas AG; 3 Tufts Medical Center, Boston, MA, USA.

Publikováno v: Clinical trials (London, England) [Clin Trials] 2019 Jun; Vol. 16 (3), pp. 306-315. Date of Electronic Publication: 2019 Apr 22.

Response to Comment on Lewis et al. Management of Hemoglobin Variants Detected Incidentally in HbA 1c Testing: A Common Problem Currently Lacking a Standard Approach. Diabetes Care 2017;40:e8-e9.

Autor: Lewis MR; Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT michael.lewis@uvmhealth.org., Sheehan PR; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Tufts Medical Center, Boston, MA., Staten MA; Kelly Government Solutions for National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD., Phillips LS; Atlanta VA Medical Center, Decatur, GA, and Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA., Pittas AG; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Tufts Medical Center, Boston, MA.

Publikováno v: Diabetes care [Diabetes Care] 2017 Oct; Vol. 40 (10), pp. e150-e151.